The rising interest in GLP-1 agonists for metabolic conditions has generated a discussion about delivery routes : skin-applied devices versus pills . Usually , GLP-1 therapies were exclusively available https://rafaelwgvd347312.blog-kids.com/41367930/glp-1-transdermal-delivery-systems-vs-pills-what-right-for-you